Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 19 July 2013 | By Louise Zornoza,
Brazil's National Agency for Sanitary Surveillance (Anvisa) will soon open a Public Consultation (No. 26/2013) on a proposal to permit the production of veterinary pharmaceuticals, medical devices, cosmetics and toiletries in the same manufacturing site where human medicines are produced, it has announced.
Anvisa's said the proposal would, in its opinion, bring Brazil into alignment with regulatory policies in most other countries surveyed by the agency. Anvisa noted the need for public feedback on the proposal, given the complexity of the issue with the involvement of multiple regulated product sectors.
The proposal will be open to public consultation starting 22 July 2013.
ANVISA Proposal
Read all Breaking News from RegLink
Tags: brazil
Regulatory Focus newsletters
All the biggest regulatory news and happenings.